NCT06613204 STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners
| NCT ID | NCT06613204 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Oregon Health and Science University |
| Condition | Frontotemporal Dementia |
| Study Type | INTERVENTIONAL |
| Enrollment | 640 participants |
| Start Date | 2025-06-23 |
| Primary Completion | 2029-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 640 participants in total. It began in 2025-06-23 with a primary completion date of 2029-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this nationwide study is to test STELLA-FTD (Support via Telehealth: Living and Learning with Advancing Alzheimer's Disease)-FTD, an intervention to specifically address the needs of family Care Partners of persons with frontotemporal degeneration (FTD). STELLA-FTD is a multicomponent videoconference-based intervention designed to facilitate effective use of community and peer resources to foster effective management of behavioral and psychological symptoms of dementia. The study is recruiting families from across the United States.
Eligibility Criteria
Inclusion Criteria: Family Care Partner * Adult caring for family member with FTD. * Provides 4 or more hours of care/week. Does not have to reside with. * Identifies at least 2 moderately upsetting behaviors in the person with FTD. * Speaks and understands English to be able to participate in intervention. * Owns a telephone (smartphone, cell phone or landline). * Has email and mailing address to receive computer, study materials and surveys. * Provides informed consent to participate in the research. * Lives in the US Inclusion Criteria: Person with FTD * Diagnosis of FTD * Family member of a Care Partner (this can be a relative, spouse, or close kin that is considered family). * Lives in US Exclusion Criteria: Person with FTD * No Frontotemporal Degeneration diagnosis. * Unable to leave Care Partner during STELLA-FTD sessions. * Enrolled in hospice. Exclusion Criteria: Family Care Partner * Unable to find activity for Care Recipient during STELLA-FTD sessions to allow Care Partner to work privately with Guide and other Care Partners. * Hearing and/or vision problems severe enough to prevent participation. * Refuses to be video-recorded during STELLA-FTD sessions. * Unwilling or unable to adequately follow study instructions and participate in study procedures.
Contact & Investigator
Allison Lindauer, PhD, APRN
PRINCIPAL INVESTIGATOR
Oregon Health and Science University
Frequently Asked Questions
Who can join the NCT06613204 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Frontotemporal Dementia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06613204 currently recruiting?
Yes, NCT06613204 is actively recruiting participants. Contact the research team at chatterton@ohsu.edu for enrollment information.
Where is the NCT06613204 trial being conducted?
This trial is being conducted at Portland, United States.
Who is sponsoring the NCT06613204 clinical trial?
NCT06613204 is sponsored by Oregon Health and Science University. The principal investigator is Allison Lindauer, PhD, APRN at Oregon Health and Science University. The trial plans to enroll 640 participants.